No Data
No Data
XORTX Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Stocks in Play: XORTX Therapeutics Inc.
XORTX Therapeutics Adjusts Warrant Terms
XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection With October 2021 US IPO
07:01 AM EDT, 05/17/2024 (MT Newswires) -- XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO
XORTX Reprices Balance of Warrants Issued in Connection With October 2021 US IPO
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing
Xortx Therapeutics Q1 Financial Snapshot
No Data
Salmon Klein : ypu did well...I got in for a quick 5% gain and didn't take my order (doing something weird in black pools look like) and in the next candle hit my SL...2 days in a row losing wtf!!
FattyChickOP Salmon Klein: Go for a more quality stock, which >100mil mcap.